HSKA (US42805E3062)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets.
MARKET: Nasdaq
Fair value: $ 56
Discount:
Average yearly return: 51%
Yield: N/A
Outperformer
November 1, 2016
Heska Corp reports record third quarter results * Q3 earnings per share $0.45 * Q3 revenue $33.4 million
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets.
MARKET: Nasdaq
Fair value: $ 56
Discount:
Average yearly return: 51%
Yield: N/A
Outperformer
November 1, 2016
Heska Corp reports record third quarter results * Q3 earnings per share $0.45 * Q3 revenue $33.4 million
No comments:
Post a Comment